REGISTERED NUMBER: 02156591 (England and Wales)

Unaudited Financial Statements

for the Period

1 March 2025 to 25 November 2025

for

Park Avenue Pharmacy Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

J V Evans

N D S Sangha

K A Simpson

REGISTERED OFFICE:

10 Park Avenue

Redcar

Cleveland

TS10 3JZ

REGISTERED NUMBER:

02156591 (England and Wales)

ACCOUNTANTS:

Anderson Barrowcliff Limited

Chartered Accountants

3 Kingfisher Court

Bowesfield Park

Stockton on Tees

TS18 3EX

FIXED ASSETS

Tangible assets

4

5,909

5,844

Investments

5

4,031

4,031

9,940

9,875

CURRENT ASSETS

Stocks

6

57,007

47,596

Debtors

7

188,427

163,703

Cash at bank and in hand

109,834

40,165

355,268

251,464

CREDITORS

Amounts falling due within one year

8

180,362

129,453

NET CURRENT ASSETS

174,906

122,011

TOTAL ASSETS LESS CURRENT LIABILITIES

184,846

131,886

CAPITAL AND RESERVES

Called up share capital

9

2

2

Retained earnings

184,844

131,884

SHAREHOLDERS' FUNDS

184,846

131,886

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 25 November 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 25 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 August 2026 and were signed on its behalf by:

N D S Sangha - Director

1.	STATUTORY INFORMATION

Park Avenue Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 20% on cost

Motor Vehicles - 25% on cost

Computer Equipment - 25% on cost

Investments in subsidiaries

Investments in associates are measured at cost less impairment.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit and loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease,

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 14 (2025 - 17 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1 March 2025

46,434

13,476

59,910

Additions

-

1,429

1,429

At 25 November 2025

46,434

14,905

61,339

DEPRECIATION

At 1 March 2025

46,015

8,051

54,066

Charge for period

106

1,258

1,364

At 25 November 2025

46,121

9,309

55,430

NET BOOK VALUE

At 25 November 2025

313

5,596

5,909

At 28 February 2025

419

5,425

5,844

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 March 2025

and 25 November 2025

4,031

NET BOOK VALUE

At 25 November 2025

4,031

At 28 February 2025

4,031

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Clevechem Limited

Registered office: Redcar Primary Hospital, West Dyke Road, Redcar, TS10 4NW

Nature of business: Pharmacy

%

Class of shares:

holding

Ordinary

10.55

6.

STOCKS

2025

2025

£

£

Stocks

57,007

47,596

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2025

£

£

Trade debtors

98,544

88,928

Amounts owed by group undertakings

85,756

57,661

VAT

222

11,102

Prepayments

3,905

6,012

188,427

163,703

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2025

£

£

Trade creditors

94,599

109,466

Accruals

84,626

2,240

Amounts owed to group undertakings

-

13,307

Taxation

1,137

-

Social security and other taxes

-

4,440

180,362

129,453

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2025

value:

£

£

2

Ordinary

1

2

2

10.	OTHER FINANCIAL COMMITMENTS

The total amount of financial commitments not included in the statement of financial position is £32,458 (28 February 2025 - £50,958).

11.	ULTIMATE CONTROLLING PARTY

The company's parent company is Coopers Healthcare Group Limited, who's registered office is 4 Hadrian Way, Ingleby Barwick, Stockton-on-Tees, TS17 5LN.